Codexis sells its operations in Hungary to US biotech firm Intrexon
17:09 PM | March 14, 2014 | Deepti Ramesh
Codexis (Redwood City, CA), a developer of biocatalysts for the pharmaceutical and fine chemical industries, says it has sold its subsidiary and laboratory operations at Budapest, to biotechnology...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.